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CHAPTER I
INTRODUCTION

1.1

Hemoglobin Oxidation

Hemoglobin (Hb) oxidation is important to the physiology and pathophysiology of red
blood cells (RBCs). The conversion of ferrous Hb to ferric Hb not only inactivates Hb, but
also produces Heinz bodies in RBCs (Jacob, 1970).

Extensive jnvestigations on Hb

autoxidation have been carried out with purified Hb in various buff er systems (Weiss, 1964;
Misra and Fridovich, 1972; Winterboun, l 985a; Caughey and Watkins, 1985).

Some

environmental pollutants and drug molecules have also been found to affect Hb oxidation
(Kiese, 1976; MacDonald and Charache, 1982; Winterboun, 1985b). Most of these studies
were carried out in the absence of membrane components. The mechanism for Hb oxidation
in the presence of erythrocyte membrane components may differ from that of Hb in buffer.
Thus, for studies of normal Hb (HbA) or mutant Hb oxidation, or the effects of pollutants or
drug molecules on Hb oxidation, it is desirable to study the oxidation behavior in the presence
of erythrocyte membrane components, such as intact membranes, membrane lipids or
membrane proteins.
In our previous study, we found that the Hpid Yesicles enhanced Hb oxidation
(LaBrake and Fung, 1992). It has been suggested that the hydrophobic properties of lipid
vesicles enhances the partitioning of heme in lipid phase (LaBrake and Fung, 1992). The
overall mechanism for enhancing Hb oxidation by lipid Yesicles is likely to be quite
complicated. A more systematic study is needed.
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1.2

Hemoglobin/Phospholipids Interaction and Heme Transfer

We chose bovine brain phosphatidylserine (BPS) as the lipid for preparing vesicles
because phosphatidylserine (PS) is one of the major phospholipid components found in the
inner leaflet of the erythrocyte membrane bilayer (Marinetti and Crain, 1978). We have used
the 35 mM sodium phosphate buffer with 2 mM ethylenediaminetetraacetic acid (EDTA) and
110 mM sodium chloride at pH 7.4 (147PEN7.4) for heme transfer experiments in most of
our studies because 147PEN7.4 buffer has pH and ionic strength similar to that of blood.
In past studies, it has been found that Hb interacts with erythrocyte membranes. This
interaction is stronger at lower ionic strength (Fung, 1981; Kaul and Kohler, 1983) than at
physiological ionic strength (Lilley and Fung, 1987). Hb also interacts with phospholipids.
The electrostatic interactions (Szundi et al., 1980) and the hydrophobic interactions (Calissano
et al., 1972; Papahadjopoulos et al., 1973) between Hb and PS have been observed. A model
has been proposed to suggest that Hb interacts with the lipid surface initially by charge
interactions, followed by insertion of the hydrophobic part of the globin into the lipid bilayer
(Kimelberg, 1976). Shviro and coworkers (Shviro et al., 1982) suggested that the hydrophobic
interactions in the model referred to a transfer of hydrophobic heme groups from Hb to the
lipid bilayer, rather than a specific globin moiety interacting hydrophobically with PS.
Although apomyoglobin and apohemoglobin can ex.tract heme from the lipid bilayer (Rose et
al., 1985; Cannon et al., 1988), the affinity between carbon monoxide (CO)- heme and globin
(Light and Olson, 1990) is higher than that of hemin and globin (Cannon et al., 1988). In the
presence of PS no interaction was found between globin and hem in (Shviro et al., 1982). The
heme transfer rate constant between Hb and hernopexin was not detectable for carbon
monoxide ligated Hb (HbCO), whereas it was 0.9 h- 1 for methemoglobin (Hebbel et al., 1988).
In this work, instead of monitoring transfer of heme from Hb to hemopexin, we monitored
the transfer of heme from Hb to lipid vesicles in 147PEN7 .4 buffer at a specific level of
oxyHb oxidation.

3
1.3

Overview of Sickle Hemoglobin Studies

Sickle cell disease is the consequence of the presence of sickle Hb (HbS) inside RBCs.
The existence of sickle-shaped erythrocytes in human blood was first discovered by Herrick
in the early part of this century (Herrick, 1910). The alteration of hemoglobin molecule in
sickle cells was identified with electrophoretic mobility by Pauling and his colleagues in 1949
(Pauling et al., 1949). Then Ingram showed that the molecular abnormality was due to the
substitution of a single amino acid, valine for glutamic acid residue at the sixth position of
hemoglobin (3 chain (Ingram, 1956). In the last quarter of a century, understanding of the
molecular pathophysiology, diagnosis, and treatment of sickle cell disease has come from
striking results in the application of x-ray diffraction, electron microscopy, thermodynamic
and kinetic analyses, nuclear magnetic resonance spectroscopy, restriction enzyme mapping,
and differential gene expression studies (Schechter et al., 1987; Nagel, 1991 ).
There is little quantitative information in the literature on the stability of the link
between the heme and the glob in in HbS although Hb is prn babl y the most thoroughly
investigated of all proteins. But hemin build-up is observed both on the membrane (Shaklai
et al., 1985; Kuross et al., 1988; Sugihara et al., 1992) and in the hemolysate of sickle cells
(Liu et al., 1988).

Hemin build-up on sickle cell membranes has been attributed to

accelerated oxidation of HbS (Hebbel et al., 1988; Hebbel, 1990; Hebbel, 1991), instability of
HbS at the air-water interface (Asakura et al.,

1973~

Elbaum et al., 1976), or aggregation of

hemichrome with membrane proteins, mostly Band 3 (Kannan et al., 1988).

Hebbel has

hypothesized that sickle cell disease is partly a disorder of autoxidation and iron
decompartmentalization (Hebbel and Foker, 1986). NeYertheless, the mechanism of sickle cell
disease is still not clear.

CHAPTER II
MATERIALS AND METHODS

2.1

Materials

All chemicals used for this thesis work were reagent grade from Fisher Scientific
(Pittsburgh, PA), Sigma Chemical Co. (St. Louis, MO) or Aldrich Chemical Co., Ins.
(Milwaukee, WI). HPLC-grade water was used for all buffers. All glassware was cleaned
with chromic acid and well washed with deionized distilled water before use. Unless stated
otherwise, all experimental steps were carried out at 4 °C. Human adult normal RBCs were
obtained from a local blood bank (Red Cross/LifeSource), with CPDA-1 or ADSOL used for
anticoagulant. Sickle RBCs samples from adult homozygous patients with sickle cell anemia
disease were collected into heparinized, EDTA, or citrate-coated tubes at either Mount Sinai
Hospital, Chicago, IL, or George Washington Hospital, Washington, DC.

2.2 Hemoglobin Preparation
2.2.1

Hemolysate Preparation
Hemolysate from the sickle RBCs was prepared in tandem with normal hemolysate as

follows. The RBCs were used within one week of withdrawal and washed with 5 mM sodium
phosphate containing 150 mM sodium chloride, saturated with CO, at pH 7.4. The cells were
lysed with 2 volumes of deionized water, followed by ammonium sulphate precipitation and
desalting with a P6DG column (BioRad, Richmond, CA). equilibrated with 5 mM tris(hydroxymethyl)aminomethane (Tris) buffer containing 150 mM sodium chloride at pH 7.5
to remove ammonium sulphate and other small molecules, including 2,3- biphosphoglycerate,
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which affects hemoglobin autoxidation (Mansouri and Winterhalter, 1974; Kikugawa et al.,
1981), to give stripped hemolysate. The hemolysate solution was dialyzed against 147PEN7.4
buffer, saturated with CO. If not used immediately, the hemolysate was frozen drop-wise in
liquid nitrogen (N 2 ) and stored at - 80 °C. After thawing, the hemolysate was centrifuged at
38,000 g for 10 minutes before use.

2.2.2

Hemoglobin Preparation
The stripped hemolysates were dialyzed in 50 mM Tris buffer with 0.1 mM EDTA at

pH 8.3 (50TE8.3), followed by CO gassing. HbS was isolated from the stripped and dialyzed
hemolysate solution, in tandem with HbA, according to a modified column chromatograph
procedure (Kawanishi and Caughey, 1985; Watkins et al., 19&5; Winterbourn, l 985a). A
DEAE-Sephadex A-50 (Pharmacia, Piscataway, NJ) column was used with a linear pH
gradient made from 50TE8.3 buffer and a similar buffer at pH 7 .0. The HbS fractions eluted
at pH 7.90 and the HbA eluted at pH 7.75.

The HbS and HbA fractions were pooled,

concentrated, dialyzed against 147PEN7.4 buffer, and CO gassed to give HbCO.

This

procedure removed all minor hemoglobin components, catalase, superoxide dismutase,
"adventitious" metals, and other red cell proteins to give "ultra-pure" Hb (Watkins et al., 1985;
Winterbourn, 1985a). If not used immediately, the Hb was frozen drop-wise in liquid N 2 and
stored at -80 °C.

2.2.3

Hemoglobin Concentration
The total Hb concentration in the Hb solution was determined by the Winterbourn

method (Winterbourn, l 985a).

At the beginning of each oxidation experiment, the

concentration of the oxygenated Hb (OxyHb) solution was determined at 577 nm, using an
extinction coefficient of 15.0 mM- 1 cm- 1 (Winterbourn, l 9~5a).
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2.2.4

Sickle Hemoglobin Assay
Hemoglobin electrophoresis method was performed to ensure the identity of sickle

hemoglobin.

Briefly, 100 ml of Supre Heme diluted solution was poured within the

compartments of the electrophoresis chamber. HbS and control sample (HbA) were loaded
on pretreated Titan 111-H Cellulose Acetate Plate (Helena Laboratories, Beaumont, TX).
Electrophoresis was conducted at 350 V for 25 minutes. Then the plate was stained for 5
minutes in Ponceau Sand destained in 3 successive washes of 5 % acetic acid for 2 minutes
each.

2.3
2.3. l

Vesicles Preparation

Lipid Vesicles
Bovine brain phosphatidylserine was purchased from Avanti Polar Lipids, Inc.

(Alabaster, AL) and was used without further purification after verification of purity by
thin-layer chromatography. Desired amounts of BPS in chloroform solution were evaporated
to dryness using a rotary evaporator under N 2 gas. 147PEN7.4 buffer solution was saturated
with N 2 gas, and added to the lipid film. The solution was hand-swirled in the presence of
glass beads to give multilamellar vesicles.

2.3.2

Small Unilamellar Vesicles
Small unilamellar vesicles (SUVs) were prepared from the multilamellar BPS vesicle

solutions by slightly modified procedures of ltabe and coworkers (ltabe et al., 1988).
Multilamellar vesicles were sonicated for about 20 minutes using a pro be tip sonicator (Model
W-10, Heat Systems-Ultrasonics, Plainview, NY), and centrifuged at 38,000 g for 15 minutes
at room temperature to remove any large multilamellar vesicles and titanium from the
sonication probe. The SUV samples were used immediately for oxidation studies.
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2.3.3

Large Unilamellar Vesicles
Large unilamellar vesicles (LUVs) were prepared from the multilamellar BPS vesicle

solutions by extrusion methods with a lipid extruder (Lipex: Biomembranes Inc., Vancouver,
B. C. Canada). Typically, the multilamellar vesicles were frozen (in liqujd N 2 ) and thawed
(at 45 °C water bath) for five times to yield a suspension of extended bilayers, then an aliquot
(2-5 ml) of above suspensions was injected into the central chamber of the extruder, above
the polycarbonate filters (Nuclepore, Pleasanton, CA).

N 2 pressure was applied using a

standard N 2 cylinder equipped with a high pressure regulator with an output range of 0-4000
psi in 100-psi increments.

BPS vesicles were extruded at a constant pressure at room

temperature through two stacked 100 nm pore size polycarbonate filters for ten times
(Loughrey et al., 1990). The LUY samples were used immediately for oxidation studies. The
average diameter for BPS LUVs was about 110 nm, as determined by Rita Hatfield of our
laboratory, in good agreement with others (Kolchens et al., 1993).

2.3.4.

Lipid Concentration
Phospholipid concentrations of the vesicle samples were determined by the method of

Stewart (Stewart et al., 1980). Color complexes between ammonium ferrothiocyanate and
phospholipids were formed to give spectrophotometric readings at 452 nm. This method
allows measurements of phospholipids in the range 0.01-0.1 mg (15-150 nmol).

2.4
2.4. l

Rate Constant Determination

Optical Measurements of Hemoglobin and Vesicle Mixtures
HbCO was converted to oxyHb on ice under a flood light and oxygen atmosphere

immediately before the experiment. The cold oxyHb solution was introduced to a solution
of vesicles of specific lipid concentration. The Upid to Hb molar ratio were calculated using
a molecular weight of 64,000 for Hb and 810 for BPS. A solution with the same vesicle
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concentration with buffer instead of hemoglobin was used as a blank. The optical spectra
from 500- 700 nm were obtained as a function of time at 37 °C.

2.4.2

Concentration of Hemoglobin Species during Oxidation
The initial Hb sample was 100 % oxyHb. During Hb oxidation, oxyHb was oxidized

to methemoglobin, hemichrome, and choleglobin, following the definitions of Winterbourn
(Winterbourn, 1985b). Thus the absorbance values at different wavelengths can be analyzed
as a four-component (oxyHb, methemoglobin, hemichrome and choleglobin) system at 560,
577, 630 and 700 nm, to determine the concentrations of each Hb species in oxidized samples
(Winterbourn, 1985a). The concentration of a component was set to zero if the analysis gave
a negative value. The total Hb concentration at later time during Hb oxidation was similar
with the initial total Hb concentration.

The amounts of oxidized Hb (methemoglobin,

hemichrome and choleglobin) at different time divided by the total amount of Hb (oxyHb,
methemoglobin, hemichrome and choleglobin) in solution were calculated to give percent
oxidized Hb at different times.

2.4.3

Rate Constant Determination
Pseudo first-order rate constant (k) for the disappearance of ox:yHb or the formation

of oxidized Hb was obtained by a linear regression method from the linear portions of the
logarithmic values of percent oxyHb disappearing or remaining in solution versus time plots.

2.5
2.5.1

Heme Assay

Separating Vesicles and Hemoglobin
1 ml of Hb (0.78 mg/ml) was mixed with 2 ml of BPS LUVs (3.2 mg/ml) and

incubated at 37 °C. The vesicles and Hb in vesicle-Hb samples at different degrees of Hb
oxidation were separated by gel filtration on a Sepharose 48-Cl (Pharmacia, Piscataway, NJ)
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column (41cmx1.5 cm) with a flow rate of 12 ml/h (Szebeni et al., 1988; LaBrake and Fung,
1992). The vesicles eluted at the void volume about 2.3 hours after sample loading. The Hb
eluted about 3 hours later, thus yielding a very clean separation of vesicles and Hb. The
vesicle fractions were pooled and pelleted by centrifugation at 160,000 g for 2 hours. The
pellet was then taken up in a small volume of buffer (100-150 µI).

2.5.2

Heme Concentration in lipid vesicles
Fluorescence method was used to determine heme concentration in vesicles (Morrison

et al., 1965; LaBrake and Fung, 1992). In the heme assay, the heme or hemin was converted
to porphyrin for fluorescence detection (Morrison, 1965; Shaklai et al., 19&5). A calibration
curve was prepared using 50 µl of Hb solutions ranging from 0.31 µM to 3.13 µM in heme
(0.005 to 0.05 mg/ml in Hb) and 2 ml oxalic acid solution. The mhture was vortexed and
incubated at 100 °C for 30 min. After cooling to room tempeature, fluorescence intensity
was measured using an excitation wavelength of 403 nm and an emission wavelength of 601
nm.

For a 25 µl vesicle sample, 3 ul of 100% of Triton X-10() solution was needed to

solubilize the lipid, followed by 1 ml of oxalic acid solution for fluorescence measurements.
Heme concentrations were converted from fluorescence readings via the calibration curve and
dilution factor used. The % heme was calculated as the amount of heme in vesicles separated
from Hb divided by the amount of heme in initial mixture. The amounts of heme in both
sample were normalized to 1 mg lipid.

2.6 Statistical Analysis
The variability of the data was calculated as an average (Avg) wjth standard deviation
(SD), or coefficient of variability (CV), which was defined as the standard deviation divided
by the average. Statistical significance of the differences between normal and sickle Hb data
was analyzed with Student t-test on the slopes of normal and sickle Hb data (Zar, 1974).
Differences at p< 0.05 are usually considered significant in biological systems (Zar, 1974;
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K vanli, 1988).

CHAPTER III
RESULTS

3.1 Normal and Sickle Hemoglobin Oxidation in the Presence of Large Unilamellar Vesicles
under Low Salt and Low pH Conditions
The oxidations of HbA and HbS were studied in the presence of BPS LUVs under low
salt and low pH conditions. The rate constants for the disappearance of ox:yHb in buffer with
5 mM Tris, 10 mM potassium chloride, at pH 6.5 (15TK6.5) were obtained at room

temperature or 37 °C. When the lipid to Hb molar ratio was about 130, HbS exhibited a kLUV
for the disappearance of oxyHb of 16.1 h- 1 , compared to 5.0 h- 1 for HbA, at 37 °C (Figure
1). With the similar lipid to Hb molar ratio at room temperature, HbS and HbA showed the
kLUV values for the disappearance of oxyHb as 12.8 h- 1 and 3.6 h- 1 , respectively (Figure 1).
Notably, the k values were much larger for HbS than for HbA at both 37 °C and room
temperature. The ratios of k values for HbS over HbA in the presence of BPS LUVs were
3.2-fold at 37 °C and 3.6-fold at room temperature. Marva and Hebbel have found that the
HbS has a 3.4-fold faster oxidation than those of HbA in the presence of dioleoyl-PS LUVs
at room temperature (Marva and Hebbel, 1994). The oxidation data were also supported by
the data from absorbance at 412 nm. Addition of either ox:yHb to BPS L UVs resulted in a loss
of absorbance at 412 nm, the rates of which were faster for HbS than for HbA at both 37 °C
and room temperature as shown in Figure 2. Part of the Loss in absorbance at 412 nm was
caused by peak absorbance shifted from its value of 412 nm to 410 nm resulting from
conversion of oxyHb to oxidized Hb (Marva and Hebbel, 1994).
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Figure 1.

A semi-logarithmic plot of % oxyHb nrsus time.

Pseudo first-order rate

constants for the disappearance of oxyHbA ( O) or oxyHbS (D ) in the presence of BPS LUVs
incubated at room temperature (open symbols) or 37 °C (filled symbols) versus time in
15TK6.5 buffer. The lipid to Hb molar ratio was about 130. The l:ines are linear fits through
each data type (HbA+LUVs at room temperature;
HbA+LUVs at 37 °C; HbS+LUVs at 37 °C).

HbS+LUYs at room temperature;
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Figure 2.

Plot of absorbance at 412 nm of HbA ( 0 ) or HbS (0 ) in the presence of

BPS LUVs incubated at room temperature (open symbols) or 37 "C (filled symbols) versus
time in 15TK6.5 buffer. The vesicles were prepared by extrusion 10 time through a 100 nm
polycarbonate filter with a lipid concentration of 0.44 mg/ml and a Hb concentration of 0.26
mg/ml. The lipid to Hb ratio was about 130.
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3.2

Normal and Sickle Hemoglobin Oxidation under Low Salt and Physiological pH
Conditions
The oxidations of HbA and HbS were also studied in the presence of BPS LUVs at

37 °C under 35 mM phosphate buffer with 2 mM EDTA and 10 mM sodium chloride at pH
7.4 (47PEN7.4) or under 35 mM Tris buffer with 2 mM EDTA and 10 mM sodium chloride
at pH 7.4 (47TEN7.4). Under 47PEN7.4 buffer, HbS shows the similar level of oxidized Hb
with those of HbA during 3 hours incubation. The kLUV for the initial disappearance oxyHb
in the presence of BPS LUVs was 0.15 h- 1 for HbS, compared to 0.14 h- 1 for HbA. Under
47TEN7.4 buffer, the kLUV for the initial disappearance oxyHb jn the presence of BPS LUVs
was 0.29 h- 1 for HbS, compared to 0.17 h- 1 for HbA (Figure 3). HbS shows a faster rate of
the disappearance of oxyHb than HbA. It also shows that the HbS oxidation is faster in
47TEN7.4 buffer than in 47PEN7.4 buffer.

However, the difference in kLUV between

47TEN7.4 buffer and 47PEN7.4 buffer for HbA is smaller than the difference for HbS
(Figure 3).

3.3

Normal and Sickle Hemoglobin Heme Transfer to Vesicles under Low Salt and
Physiological pH Conditions
The heme transfer from HbA and HbS to vesicles were st11died in 47PEN7.4 or

47TEN7.4 buffer. In 47PEN7.4 buffer, when 24.3 % ox:yHb was oxidized jn the HbA-LUV
system, 0.27 % heme was transferred to lipid vesicles; When 26.8 % ox.yHb was oxidized in
the HbS-LUV system, 0.47 % heme was transferred to lipid vesicles. In 47TEN7.4 buffer,
when 31.4 % oxyHb was oxidized in the HbA-LUV system. 1.27 °/o heme was transferred to
lipid vesicles; When 75.1 % oxyHb was oxidized in the HbS-LUY
transferred to lipid vesicles.

~ystem,

3.37 % heme was

17

Figure 3.

A semi-logarithmic plot of % oxyHb versus time. The disappearance of

oxyHbA ( O) or oxyHbS (D ) in the presence of BPS LUVs incubated at }7 °C in 47PEN7.4
buffer (open symbols) or 47TEN7.4 buffer (filled symbols) versus 1jme.
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3.4 Normal and Sickle Hemoglobin Heme Transfer to Vesicles under Physiological Salt and
pH Conditions
It is more important to study heme transfer under buffer conditions similar to

physiological conditions. 147PEN7.4 buffer is isotonic to RBC intracellular compartment.
We studied the amount of heme transferred from Hb to both LUV and SUV vesicles in
147PEN7.4 buffer in details. Results show a linear relationship between the disappearance
of oxyHb and the heme transfer, regardless of the vesicle type, for both HbA and HbS (Figure
4).

The linear regression analysis of the correlation between heme transfer and oxyHb

oxidation rendered a slope of 0.0099 for HbA and 0.0104 for HbS (Figure 4). The ratio of
these two slopes (HbS/HbA) was 1.05. Statistical analysis of the slopes of HbS and HbA data
with Student's t test gave at value of 2.132. Thus with P < 0.05 (95 % confidence level), the
differences observed between HbS and HbA was statistically significant.
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Figure 4.

Heme concentration in BPS vesicles in HbA - SUV (D ) , HbS - SUV (• ),

HbA - LUY ( 0 ), HbS - LUY ( e

) samples as a function

of ()Jddized Hb concentrations.

OxyHb was incubated with 2.1 mg/ml BPS vesicles at lipid to Hb molar ratio of about 650 in
147PEN7.4 buffer at 37 °C for various time periods. At the end of each time period, the
percentage of Hb oxidized to ferric species, including choleglo bin, and the percentage of
heme transferred to vesicle phase were determined. The top line is the linear regression line
for samples of HbS in the presence of either SUVs and LUVs.

The slope is 0.0104 (r 2

=

0.998). The bottom line is for samples of HbA in the presence of either SUVs or LUVs. The
slope is 0.0099 (r 2

= 0.996). The ratio of the slopes (HbS/HbA) is I .05. The small differences

between the two sets of data are statistically significant (t

=

2.132 and p-< 0.05).

21

~

~

0.8

Cl)

s
Cl)

~

0.4

o. o---__.....__...__---'--_._____,
0

20

40

60

80 I 00

Oxidized Hb

(%)

CHAPTER IV
DISCUSSION AND CONCLUSION

The HbS mutation at {36 Glutamic acid

-+

Valine renders the molecule more

hydrophobic than HbA and gives a solution surface conformation slightly different from that
of HbA, as demonstrated by proton nuclear magnetic resonance studies (Fung et al., 1975).
The observed changes in surface conformation provide a possible explanation for the airwater instability of HbS. It has also been reported that partially denatured hemoglobin rapidly
and reversibly copolymerizes with the cytoplasmic domain of Band 3 into an insoluble
macromolecular aggregate (Waugh and Low, 1985; Waugh et al., 1986; 1987). Thus, all of
these experimental findings provide much speculation and yet very attractive molecular
mechanisms for the build-up of hemin on sickle cell membranes. Our recent finding that HbS
oxidation in the presence of lipid is abnormal as compared to HbA. Experimental evidence
shows that, in buffer at acidic pH and low ionic strength, lipid enhanced Hb oxidation is 3.4
times faster for HbS than HbA (Marva and Hebbel, 1994). Since these studies were carried
out at pH 6.5 with an ionic strength lower than that at physiological conditions, we carried
out studies in phosphate buffer at physiological pH and ionic strength conditions.

4.1

Comparison of Hemoglobin Oxidation between Different Salt and pH Conditions:
Normal and Sickle Hemoglobin
Interactions of oxyHbS with PS liposomes in vitro lead to complex changes that may

be informative with regard to sickle disease pathophysiology. In our studies, we used BPS
liposomes since PS is a major component of the RBC membrane's inner monolayer lipids (van
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Deenen and Gier, 197 4 ).
Recent work (Marva and Hebbel, 1994) has shown the HbS exhibits a significantly
higher oxidation rate than normal Hb in the presence of lipid in Tris buffer at low salt and
low pH values. Our results showed that the pseudo first order rate constants for the initial
disappearance of oxyHb and the formation of ferric species (methemoglobin and hemichrome)
and of choleglobin in the presence of small or large unilamellar vesicles under approximately
physiological conditions, in 147PEN7.4 buffer and 37 °C, were much smaller than those in
Tris buffer at low salt and low pH values. The differences between HbS and HbA rate
constants in 147PEN7.4 buffer were also smaller than the differences in Tris buffer at low salt
and pH values. HbS also exhibited only a slight (- 20 %) increase in rate constants for the
disappearance of oxyHb in 147PEN7.4 buffer over HbA. This small difference in oxidation
rate appeared to be statistically significant. However, the corresponding rate constants for
the formation of ferric species and choleglobin exhibited no significant difference between
HbS and HbA (LaBrake et al, 1994).
Our results showed that the rate constant for the disappearance of oxyHb in the
presence of LUVs at 37 °C in 15TK6.5 buffer was 5.0 h- 1 for HbA, and 16.1 h- 1 for HbS at
the lipid to Hb molar ratio of 130. These data suggest that Hb oxidation in the presence of
vesicles was about 3 times faster for HbS than for HbA in 15TK6. 5 buffer. When oxidation
rates are very fast, one will have less reliable data than when oxidation rates are slower to
allow operators to collect more data points before the oxidations are over. Since the Hb
oxidation rate in the presence of vesicles is linear with the lipid to Hb molar ratio, the lower
ratio we use, the slower the rate we will have. So the lipid to Hb molar ratio which we used
here was kept low in 15TK6.5 buffer.
In our previous studies in 14 7PEN7.4 buffer, we found that the extruded BPS L UV s
enhanced Hb oxidation to a lesser extent than sonicated SUVs, at similar lipid to Hb molar
ratio. For LUVs at about 2 mg/ml lipid concentration and 0.2 mg)ml Hb (lipid to Hb molar
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ratio= 800), kLUV were about an order of magnitude higher than kauto (0.030 h- 1 for HbS and
0.025 h- 1 for HbA), but an order of magnitude smaller than ksuv. The LUY-enhanced
oxidation rate constants for the disappearance of oxyHb also depended linearly on lipid to Hb
molar ratio, with a slope of 0.00021 to give kLUV (h- 1 ) = kauto (h- 1 ) + 0.21x10- 3 x lipid/Hb
(molar ratio) for HbS, and with a slope of 0.00018 to give kLUV (h- 1) = kauto (h- 1) + 0.18 x
10- 3 x lipid/Hb (molar ratio) for HbA (LaBrake and Fung, 1992). Using the above equation
with lipid to Hb molar ratio= 130, kLUV (147PEN7.4) = 0.049 h- 1 for HbA, and 0.058 h- 1 for
HbS. The ratio of these 2 constants is about 1.2 in 147PEN7.4 buffer. Under 15TK6.5
buffer, kLUV (15TK6.5) = 5.0 h- 1 for HbA, and 16.l h- 1 for HbS. The ratio of these 2
constants is about 3.2. Clearly, the values are much more higher in l 5TK6.5 buffer than those
in 147PEN7.4 buffer. However, buffer 15TK6.5 and buffer 147PEN7.4 are quite different.
15TK6.5 is Tris buffer, at pH 6.5, with only 5 mM potassium chloride and 10 mM Tris, and
14 7PEN7.4 is phosphate buffer, at pH 7 .4, with 110 mM sodium chloride, 2 mM EDT A and
35 mM phosphate. Assuming no significant difference between Tris and phosphate buffers
toward Hb oxidation, the major differences between oxidations in 147PEN7.4 and 15TK6.5
are due ionic strength and pH effects. This part of my work is preliminary in nature at this
point. More experiments are needed to understand salt and pH effects.

4.2

Comparison of Heme Transfer to Vesicles between Different Salt Concentration at
Physiological pH: Normal and Sickle Hemoglobin
Previous studies from Hebbel's group have shown that tile initial heme transfer in 100

mM sodium phosphate at pH7 .2 buffer from oxyHb to hemopex:in is 1. 7 times faster for HbS
when compared with HbA (Hebbel et al., 1988). It was suggested that tile accelerated heme
transfer was due to accelerated autoxidation. In our studies, instead of monitoring transfer
of heme from Hb to hemopexin, we monitored the transfer of heme from Hb to lipid vesicles
in 147PEN7.4 buffer at a specific level of oxyHb oxidation. We did not find much difference
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between the heme transfer from Hb to lipid bilayer for HbS and HbA at all levels of Hb
oxidation.
We also studied heme transfer under 4 7TEN7 .4 and 47 PEN7 A buffer.

Under

47PEN7.4 buffer, the heme transfer from HbA to vesicles was only about half amount of
heme transfer to vesicles comparing with HbS. Under 47TEN7.4 buffer, heme transfer was
larger for HbS than those for HbA. Both HbS and HbA heme transfer in 4 7TEN7 .4 buffer
were also larger than those in 47PEN7.4 buffer.
Was the Tris buffer unique with on the heme transfer to

ve~dcles?

Further studies

might provide an answer to this question.

4.3

Summary

We found that the differences in oxidation between HbS and HbA were much smaller
than those at low pH and ionic strength conditions. There was a marked different between
the oxidation rate for the HbS as compared to the HbA system under l STK6.5 buffer. This
difference was also evident under 47TEN7.4 buffer. The linear relationship finding is in
agreement with our hypothesis that the lipid enhanced Hb oxidation is correlated to the
transfer of heme from Hb to vesicles (LaBrake and Fung, 1992). Earlier kinetic data show
that SUVs exerted a larger effect toward Hb oxidation than L UVs,

suggesting that the

differences between SUV and LUY effects were due to differences in surface chemistry in
SUVs and LUVs (Labrake and Fung,1992). The lipid surface facilitated the transfer of
oxidized heme from Hb to vesicles.

Thus vesicles with higher surface curvature and

hydrophobicity, namely SUVs, would promote Hb oxidation to a larger extent than the
vesicles with lower surface curvature and hydrophobicity, namely LUVs. The amount of
heme transfer to lipid vesicles is expected to depend on the extent of oxyHb oxidized, and this
correlation would be independ of vesicle type. Our experiment a.I data were in good agreement
with this hypothesis. The results in my work and in the work of others in our laboratory
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suggest that HbS has a higher affinity for lipid surfaces than HbA. When HbS was added to
vesicles, the vesicles increased their sizes faster (about 2-fold) and to a larger extent than in
the presence of HbA. We show that this enhanced Rb-lipid surface interaction in HbS does
not induce additional HbS precipitation upon agitation, Our results suggest that the hemin
build-up in sickle cell membranes probably does not result from accelerated HbS oxidation
or HbS instability at the air-water interface, but is more likely due to other mechanisms, such
as hemichrome aggregation with membrane proteins due to an enhanced affinity of HbS
toward lipid surfaces and membrane protein.
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